Anxiety Disorder Treatment Research
Anxiety Disorder Treatment Research
Decision 1: begin Zoloft 50 mg po daily.
Reasons for the decision
Ordinarily, the patient should not be subjected to higher levels of dosage but should be given other medications that are less aggressive and which are meant to see them progress. Therefore, this reason was settled on to see to it that the patient took the Zoloft 50 mg PO orally on a daily basis to have the anxiety reduced to manageable levels. It is at this level that it is possible for the physicians to observe the drug reactions and the patient responses and be able to determine the outcome. Through this, they can make an informed decision on what to determine next (DiTomasso, & Gosch, 2007) Anxiety Disorder Treatment Research .
By this choice, I was hoping to achieve reduced level of anxiety in the patient given the fact that the prescribed medication acts by slowing the absorption rates of the serotonin substance. Therefore, at least two symptoms of the condition would be reduced. The drug dosage in the amount determined is recommended for the problem. I hoped that the problem be solved to a considerable level.
The expectations were ripe. This was not however, correspondent to the outcome. At the time of the visit, there were notable changes in the patient. The changes were marked by reduced chest pains, tightness and breath. The patient was also less anxious compared to the time of admission (Feinstein, & Eden, 2011). At the onset of the drug administration, the patient registered a HAM-A score of 8 reductions from the initial reading of 26 (Hamilton, 1959). This serves as a referral to the patient and the physician to the following decision that highly depends on the outcomes, decision 1.
ORDER A FREE-PLAGIARISM PAPER NOW
Decision 2: Increase dose to 75 mg orally daily.
Reason for the choice
Decision two serves as the most effective for the patient in that the results from decision one do not necessitate the need for another intervention. The drug had a positive effect on the anxiety disorder of the patient (DiTomasso, & Gosch, 2007). The decision to increase the dosage was to ensure that some symptoms of the client’s anxiety will be reduced and that the HAM-A scores would be reduced.
The past dosage resulted in an improvement on the side of the client in terms of the symptoms exhibited such as breathe shortage and chest complications. Other complications arising from the condition would be corrected to normal levels.
Differences in Outcome
The changes registered from the outcome of administering this medication were rather unexpected. Four weeks after the client paid a visit to the physician; there were no chest tightness and shortage of breath. His anxieties on the job issue were also at reduced levels. The remarkable outcome of the medication was drawn from the HAM-A scale that had significantly reduced to ten from the previous eighteen (DiTomasso, & Gosch, 2007).
The third decision is a unique one as it makes use of the special approaches such as choosing to educate the patients on such pertinent issues as what importance, working on their weight and balancing diet among others while working on the same drug would serve them Anxiety Disorder Treatment Research .
Reasons of the choice
When a prescribe medication does not bear any positive changes on a client, then it is in the best interest of the patient to be subjected to new medications. Sometimes it becomes useful to alter dosage from previous prescriptions. In this case however, there are no such desired changes. This is rooted to make the client have an understanding of the behavioral patterns of weight loss and diet and why they should not abandon their medications on the mere fact that they lost weight (Pine, Ressler, & Rothbaum, 2015).
This is vital condition to the sense that if at all there were other medical interventions to cater for the overweight issues, then no doubt the side effects would be pronounced and the issue would be more complex. This leaves the patient with only once condition, to stick to their medications and diets unabated as this will ensure that they get the desired weight loss in a natural manner (Aschenbrenner, & Venable, 2009).
Differences in results
The intimation by the PMHNP that the clients are not likely to cope with the aspects of constant dosage quantity of Zoloft is not an effective way that would help reduce weight. The patient has to stick to his prescribed medication religiously. This is premised on the fact that an increased dosage would definitely alter the body weight of the patient and this can be a crisis on its entirety. Diet would therefore not help cut weight but a desired medication (Aschenbrenner, & Venable, 2009).
Ethical considerations in communication with clients and in treatment plan
Appropriate Prescriptions for individual levels of disorders
In bipolar disorder treatment, ethical considerations are important in that they help the physicians in administering the most appropriate medications to the case of anxiety disorder at hand, be they mild, moderate or even severe conditions (Aschenbrenner, & Venable, 2009).
Proper administration of medication
This aspect reminds every physician that they ought to make the right decisions while administering drugs to ensure that the right instructions are given and followed (Feinstein, & Eden, 2011). For instance, patients may have to take their medication with food or even be subjected to taper dosage when they discontinue the drugs. It could also be a case of changed type of medication in question, or if they have to shift from the previously prescribed medication.
A patient requiring having their prescribed medication changed is an ethical consideration and is useful in that it helps physicians by providing a guide on how to reduce the dosages on the basis of the present condition (Aschenbrenner, & Venable, 2009) Anxiety Disorder Treatment Research .
Physicians also provide education to patients on what to do or expect when under certain medications. It is also through the same studies that nurses are able to highlight to the patients the possible side effects of the drugs administered (Feinstein, & Eden, 2011). This education also helps patients in understanding the need to stick to one medication as prescribed by the physician.
Aschenbrenner, D. S., & Venable, S. J. (2009). Drug therapy in nursing. Lippincott Williams & Wilkins.
DiTomasso, R. A., & Gosch, E. A. (Eds.). (2007). Anxiety disorders: a practitioner’s guide to comparative treatments. Springer Publishing Company.
Feinstein, D., & Eden, D. (2011). Ethics handbook for energy healing practitioners. Elite Books.
Hamilton, M. (1959). Hamilton Anxiety Rating Scale. Psyctests, doi:10.1037/t02824-0
Pine, D., Ressler, K., & Rothbaum, B. O. (Eds.). (2015). Anxiety disorders: translational perspectives on diagnosis and treatment. Primer on.
Wurtzel, E. (1994). Prozac nation: Young and depressed in America. Penguin Anxiety Disorder Treatment Research .